Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Clin Urol. Jul 24, 2013; 2(2): 3-9
Published online Jul 24, 2013. doi: 10.5410/wjcu.v2.i2.3
Table 2 Clinical characteristics between patients undergoing transperitoneal robot-assisted radical prostatectomy and extraperitoneal robot-assisted radical prostatectomy
VariablestRARP (n = 50)eRARP (n = 70)
Age (yr)60.5 ± 7.5 (42-72)62.1 ± 6 (47-72)
PSA (ng/mL)8.67 ± 6.1 (2.8-34.8)8.66 ± 8.58 (1.3-71.8)
Prostate volume (cc)39.5 ± 14.66 (15-70)44.9 ± 17.4 (18-82)
Biopsy Gleason score
62630
72038
832
Pathological stage
T23751
T3a1112
T3b27
Specimen Gleason score
51
61110
73052
843
944
Cancer volume (cc)3.9 ± 3.2 (0.06-14.7)3.2 ± 3.58 (0.2-23.7)
Positive surgical margin
T213.5% of 37 patients12.7% of 48 patients
T330.5% of 13 patients22.7% of 22 patients